Table 2.
Postoperative courses of SWI, DQ/IQ, ASMs, and seizure outcome.
Patient No. | Method of evaluation | SWI (%) |
DQ/IQ |
ASMs |
Seizure outcome* | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
At diagnosis of ESES | At surgery | 3 months | 6 months | 1 year | 2 years | At diagnosis of ESES | At surgery | 3 months | 6 months | 1 year | 2 years | At surgery | 2 years | |||
1 | WISC-IV | 96 | 90 | 0 | 0 | 0 | 0 | 76 | 66 | na | na | 75 | 87 | CZP 1.5 mg ESM 300 mg VPA 600 mg |
CZP 1.5 mg VPA 600 mg |
1 |
2 | KIDS | 90 | 85 | 60 | 64 | 80 | 100 | 52 | 30 | 44 | 47 | 47 | 38 | CLB 6 mg ESM 350 mg LTG 20 mg VPA 500 mg |
CLB 6 mg ESM 350 mg LEV 250 mg VPA 500 mg |
4 |
3 | KIDS | 97 | 95 | 40 | 85 | 75 | 79 | 85 | 54 | 60 | 55 | 47 | 46 | LCM 50 mg TPM 6 mg VPA 700 mg |
VPA 900 mg | 4 |